1982
DOI: 10.1248/cpb.30.4258
|View full text |Cite
|
Sign up to set email alerts
|

Studies on antitumor agents. V. Syntheses and antitumor activities of 5-fluorouracil derivatives.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

1983
1983
2018
2018

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 18 publications
(7 citation statements)
references
References 0 publications
0
7
0
Order By: Relevance
“…1-Ethoxymethyl-5-fluorouracyl 143 was synthesized in 1978 in very poor yield (4%) by reaction of ethoxychloromethane with 5-FU 1 160 or by reaction of the silylderivative 710 of 5-FU 47 with diethoxymethane and sodium iodide (44% yield) 161 or stannic chloride (14% yield), 162 as depicted in Scheme 85.…”
Section: Galocitabinementioning
confidence: 99%
“…1-Ethoxymethyl-5-fluorouracyl 143 was synthesized in 1978 in very poor yield (4%) by reaction of ethoxychloromethane with 5-FU 1 160 or by reaction of the silylderivative 710 of 5-FU 47 with diethoxymethane and sodium iodide (44% yield) 161 or stannic chloride (14% yield), 162 as depicted in Scheme 85.…”
Section: Galocitabinementioning
confidence: 99%
“…Many new 5-FU derivatives, e.g., the glycosides of 5-FU, were synthesized to develop more effective and more selective drugs. 46 These glycosides are deemed promising as both sugar and 5-FU units are well-known biologically important compounds.…”
Section: Introductionmentioning
confidence: 99%
“…In addition, it is known that modified nucleosides and nucleotides reduce the cell mitotic activity resulting in antineoplastic [11][12][13][14][15][16] and antiviral [17] activity. 5-fluorouracil, a pyrimidine analogue and representative antimetabolite drug, is currently used as a first-line chemotherapeutic agent for the treatment of different solid tumours [18][19][20][21]. However, the clinical efficacy of 5-fluorouracil is compromised by its propensity to cause several types of dose-dependent toxicity [20,21].…”
Section: Introductionmentioning
confidence: 99%
“…5-fluorouracil, a pyrimidine analogue and representative antimetabolite drug, is currently used as a first-line chemotherapeutic agent for the treatment of different solid tumours [18][19][20][21]. However, the clinical efficacy of 5-fluorouracil is compromised by its propensity to cause several types of dose-dependent toxicity [20,21].…”
Section: Introductionmentioning
confidence: 99%